- Home
- QNCX vs BEDU Comparison
QNCX vs BEDU Comparison
Compare QNCX & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- BEDU
- Stock Information
- Founded
- QNCX 2012
- BEDU 1994
- Country
- QNCX United States
- BEDU United Kingdom
- Employees
- QNCX N/A
- BEDU N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- BEDU Other Consumer Services
- Sector
- QNCX Health Care
- BEDU Real Estate
- Exchange
- QNCX Nasdaq
- BEDU Nasdaq
- Market Cap
- QNCX 47.7M
- BEDU 47.7M
- IPO Year
- QNCX 2019
- BEDU 2017
- Fundamental
- Price
- QNCX $1.31
- BEDU $1.65
- Analyst Decision
- QNCX Strong Buy
- BEDU
- Analyst Count
- QNCX 5
- BEDU 0
- Target Price
- QNCX $8.00
- BEDU N/A
- AVG Volume (30 Days)
- QNCX 302.6K
- BEDU 6.8K
- Earning Date
- QNCX 08-12-2025
- BEDU 08-01-2025
- Dividend Yield
- QNCX N/A
- BEDU N/A
- EPS Growth
- QNCX N/A
- BEDU N/A
- EPS
- QNCX N/A
- BEDU N/A
- Revenue
- QNCX N/A
- BEDU $224,321,752.00
- Revenue This Year
- QNCX N/A
- BEDU N/A
- Revenue Next Year
- QNCX N/A
- BEDU N/A
- P/E Ratio
- QNCX N/A
- BEDU N/A
- Revenue Growth
- QNCX N/A
- BEDU N/A
- 52 Week Low
- QNCX $0.51
- BEDU $1.35
- 52 Week High
- QNCX $2.45
- BEDU $2.41
- Technical
- Relative Strength Index (RSI)
- QNCX 64.64
- BEDU 43.95
- Support Level
- QNCX $1.29
- BEDU $1.70
- Resistance Level
- QNCX $1.45
- BEDU $1.93
- Average True Range (ATR)
- QNCX 0.09
- BEDU 0.04
- MACD
- QNCX 0.03
- BEDU -0.02
- Stochastic Oscillator
- QNCX 76.74
- BEDU 0.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.